Breaking News Instant updates and real-time market news.

NVS

Novartis

$86.93

2.47 (2.92%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33

Novartis announces FDA approval for Zolgensma

AveXis, a Novartis company, announced the U.S. Food and Drug Administration has approved Zolgensma for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy, or SMA, with bi-allelic mutations in the survival motor neuron 1 gene. "Zolgensma is the first and only gene therapy approved by the FDA for the treatment of SMA, including those who are pre-symptomatic at diagnosis," the company said. Zolgensma will be made available in the U.S. and will be marketed by AveXis. Outside of the U.S., Zolgensma has PRIME, or PRIority MEdicines, designation in Europe and is being reviewed under Accelerated Assessment Procedure, and also has accelerated Sakigake designation in Japan. In the interim, AveXis has arranged to make the product available for international markets, subject to local laws and regulations, as a part of its paid Managed Access Program via a collaboration with Durbin, a third-party provider.

  • 31

    May

NVS Novartis
$86.93

2.47 (2.92%)

05/20/19
FBCO
05/20/19
INITIATION
Target $336
FBCO
Neutral
Regeneron initiated with a Neutral at Credit Suisse
Credit Suisse analyst Evan Seigerman started Regeneron Pharmaceuticals (REGN) with a Neutral rating and $336 price target. The analyst is concerned that Eylea could face "increasing headwinds" with the upcoming launch of Novartis' (NVS) brolucizumab. Further, he believes consensus estimates for the Sanofi (SNY) collaboration may be too high.
05/20/19
RBCM
05/20/19
NO CHANGE
RBCM
RBC says posting hints at Zolgensma label potentially positive for PTC, Biogen
RBC Capital analyst Brian Abrahams noted a new posting on ClinicalTrials.gov that he said "looks like" an expanded access program for Zolgensma that he believes could possibly offer some hints as to the potential label under discussion with the FDA. The most interesting parts are the inclusion criteria, which he thinks could "represent a middle ground" in terms of the breadth of label Novartis (NVS) could obtain for the drug. If the posting is predictive of Zolgensma's initial label, he said he would see it as an incremental positive for Biogen (BIIB), as it would potentially reduce the worst-case scenario of Zolgensma being approved with no age or weight restrictions. It would also be an incremental positive for PTC Therapeutics (PTCT), which Abrahams noted is looking to enter the space.
05/17/19
FBCO
05/17/19
NO CHANGE
Target $68
FBCO
Outperform
Alcon off to 'solid start' post-Novartis spin, says Credit Suisse
Credit Suisse analyst Matt Miksic reiterated an Outperform rating on Alcon (ALC) and raised his price target to $68 from $66 following the company's quarterly results, saying Alcon is off to a "solid start" following the spinoff from Novartis (NVS), and says he is incrementally more bullish on the company's revenue and growth drivers.
05/13/19
WELS
05/13/19
NO CHANGE
WELS
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo
Wells Fargo analyst David Maris believes the lawsuit by 44 states against 20 generic drugmakers will weigh on generic drug stocks this week and remain an "overhang issue for some time." Actual penalties and damages are impossible to calculate, but could be material, Maris tells investors in a research note. The analyst spoke to the Connecticut attorney general's office this morning and learned they are preparing for trial in these cases. Language the attorney general has used, such as "unprecedented" and his desire to clawback all gains from collusion, should be indicative of the states' intent, Maris writes. He believes that for a sector that is generally highly levered, and with some companies named already facing an overhang from opioid litigation like Teva (TEVA), this is "especially unwelcome news."

TODAY'S FREE FLY STORIES

NTLA

Intellia Therapeutics

$14.42

-0.32 (-2.17%)

14:09
06/24/19
06/24
14:09
06/24/19
14:09
Conference/Events
Intellia Therapeutics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

KEYS

Keysight Technologies

$86.32

-0.04 (-0.05%)

14:07
06/24/19
06/24
14:07
06/24/19
14:07
Conference/Events
Keysight Technologies management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

BX

Blackstone

$44.39

-0.66 (-1.47%)

14:05
06/24/19
06/24
14:05
06/24/19
14:05
Periodicals
Blackstone to sell Landmark Financial for roughly $600M, Reuters says »

Blackstone has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCCY

1st Constitution Bancorp

$18.00

-0.695 (-3.72%)

, SHRC

Shore Community Bank

$0.00

(0.00%)

14:05
06/24/19
06/24
14:05
06/24/19
14:05
Upgrade
1st Constitution Bancorp, Shore Community Bank rating change  »

1st Constitution Bancorp…

FCCY

1st Constitution Bancorp

$18.00

-0.695 (-3.72%)

SHRC

Shore Community Bank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHX

Athersys

$1.77

0.03 (1.72%)

14:04
06/24/19
06/24
14:04
06/24/19
14:04
Conference/Events
Athersys management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

VZ

Verizon

$58.25

0.46 (0.80%)

, FDX

FedEx

$161.57

-3.74 (-2.26%)

14:04
06/24/19
06/24
14:04
06/24/19
14:04
Periodicals
Huawei's Futurewei separates operations from corporate parent, Reuters says »

The U.S.-based research…

VZ

Verizon

$58.25

0.46 (0.80%)

FDX

FedEx

$161.57

-3.74 (-2.26%)

MSFT

Microsoft

$137.85

0.91 (0.66%)

LITE

Lumentum

$50.39

1.02 (2.07%)

FN

Fabrinet

$49.13

-0.54 (-1.09%)

CIEN

Ciena

$42.87

-0.64 (-1.47%)

NPTN

NeoPhotonics

$4.06

-0.02 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 10

    Jul

  • 30

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 13

    Nov

RAMP

LiveRamp

$49.64

-1.485 (-2.90%)

, NLSN

Nielsen

$22.57

-0.85 (-3.63%)

14:01
06/24/19
06/24
14:01
06/24/19
14:01
Recommendations
LiveRamp, Nielsen, comScore analyst commentary  »

LiveRamp acquisition of…

RAMP

LiveRamp

$49.64

-1.485 (-2.90%)

NLSN

Nielsen

$22.57

-0.85 (-3.63%)

SCOR

comScore

$7.40

-0.37 (-4.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

LAUR

Laureate Education

$15.20

-0.17 (-1.11%)

14:00
06/24/19
06/24
14:00
06/24/19
14:00
Options
Odd bullish block in Laureate Education on CBOE »

Odd bullish block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCCY

1st Constitution Bancorp

$18.00

-0.695 (-3.72%)

13:59
06/24/19
06/24
13:59
06/24/19
13:59
Upgrade
1st Constitution Bancorp rating change  »

1st Constitution Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$143.15

-10.925 (-7.09%)

13:58
06/24/19
06/24
13:58
06/24/19
13:58
Hot Stocks
PizzaRev announces partnership to offer Beyond Meat sausage topping »

PizzaRev announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
06/24/19
06/24
13:55
06/24/19
13:55
General news
Fed funds futures are firmer with Treasuries »

Fed funds futures are…

KPTI

Karyopharm

$6.30

-0.13 (-2.02%)

13:50
06/24/19
06/24
13:50
06/24/19
13:50
Options
Bullish call spread opened in Karyopharm Therapeutics »

Bullish call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

FDS

FactSet

$293.78

-4.31 (-1.45%)

, LEN

Lennar

$51.67

0.35 (0.68%)

13:46
06/24/19
06/24
13:46
06/24/19
13:46
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FDS

FactSet

$293.78

-4.31 (-1.45%)

LEN

Lennar

$51.67

0.35 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

SPOT

Spotify

$149.91

1.74 (1.17%)

, AAPL

Apple

$199.07

0.3 (0.15%)

13:46
06/24/19
06/24
13:46
06/24/19
13:46
On The Fly
Analyst says sell Spotify on publisher rates risk, competition »

Evercore ISI analyst…

SPOT

Spotify

$149.91

1.74 (1.17%)

AAPL

Apple

$199.07

0.3 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

STNG

Scorpio Tankers

$26.23

0.18 (0.69%)

13:45
06/24/19
06/24
13:45
06/24/19
13:45
Conference/Events
Scorpio Tankers management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

AG

First Majestic

$7.77

0.31 (4.16%)

13:45
06/24/19
06/24
13:45
06/24/19
13:45
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$21.23

-0.51 (-2.35%)

13:43
06/24/19
06/24
13:43
06/24/19
13:43
Conference/Events
Coherus Biosciences management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

MDEVF

Melco International

$0.00

(0.00%)

, MLCO

Melco Resorts & Entertainment

$21.41

-0.21 (-0.97%)

13:40
06/24/19
06/24
13:40
06/24/19
13:40
Recommendations
Melco International, Melco Resorts & Entertainment analyst commentary  »

Melco International could…

MDEVF

Melco International

$0.00

(0.00%)

MLCO

Melco Resorts & Entertainment

$21.41

-0.21 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$27.24

-0.45 (-1.63%)

13:35
06/24/19
06/24
13:35
06/24/19
13:35
Options
Williams put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLSA

Tiziana Therapeutics

$8.50

(0.00%)

13:32
06/24/19
06/24
13:32
06/24/19
13:32
Hot Stocks
Tiziana says newly published article supports oral monoclonal antibody platform »

Tiziana Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$262.82

0.42 (0.16%)

13:25
06/24/19
06/24
13:25
06/24/19
13:25
Options
NetEase call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$199.18

0.41 (0.21%)

13:21
06/24/19
06/24
13:21
06/24/19
13:21
Periodicals
Apple rolls out fifth iOS 12.4 beta ahead of Apple Card launch, 9to5Mac says »

Apple is rolling out the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/24/19
06/24
13:17
06/24/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFMD

Affimed N.V.

$2.97

-0.45 (-13.16%)

13:16
06/24/19
06/24
13:16
06/24/19
13:16
Hot Stocks
Affimed falls 13% after announcing clinical update on AFM13 in CD30 lymphomas »

Earlier today, Affimed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/24/19
06/24
13:16
06/24/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.